| Q2 2024 |
38 |
$1.3B |
+$61.1M |
-$121M |
-$60.2M |
BLFS, RVMD, SRPT, LAB, WGS
|
13F-HR |
8/14/2024, 04:09 PM |
| Q1 2024 |
35 |
$1.3B |
+$285M |
-$68.6M |
+$216M |
RVMD, LAB, BLFS, SRPT, RLAY
|
13F-HR |
5/15/2024, 04:05 PM |
| Q4 2023 |
36 |
$1.01B |
+$213M |
-$139M |
+$73.9M |
RVMD, BLFS, SRPT, RLAY, GPCR
|
13F-HR |
2/14/2024, 04:06 PM |
| Q3 2023 |
43 |
$892M |
+$69.7M |
-$113M |
-$43.5M |
SRPT, BLFS, EQRX, GPCR, RLAY
|
13F-HR |
11/14/2023, 04:12 PM |
| Q2 2023 |
47 |
$1.14B |
+$89.8M |
-$158M |
-$68.1M |
BLFS, SRPT, RLAY, EQRX, ALNY
|
13F-HR |
8/14/2023, 04:12 PM |
| Q1 2023 |
41 |
$1.21B |
+$162M |
-$161M |
+$811K |
BLFS, SRPT, RLAY, EQRX, ILMN
|
13F-HR |
5/15/2023, 03:01 PM |
| Q4 2022 |
46 |
$1.29B |
+$205M |
-$146M |
+$59.1M |
SRPT, BLFS, EQRX, ALNY, ILMN
|
13F-HR |
2/14/2023, 01:01 PM |
| Q3 2022 |
37 |
$1.51B |
+$284M |
-$76M |
+$208M |
EQRX, BLFS, SRPT, ALNY, BPMC
|
13F-HR |
11/14/2022, 03:18 PM |
| Q2 2022 |
40 |
$1.18B |
+$49.6M |
-$258M |
-$208M |
EQRX, ALNY, BLFS, RLAY, MXCT
|
13F-HR |
8/15/2022, 01:16 PM |
| Q1 2022 |
47 |
$2.23B |
+$29.3M |
-$207M |
-$177M |
BLFS, ALNY, EQRX, FATE, RLAY
|
13F-HR |
5/16/2022, 12:32 PM |
| Q4 2021 |
53 |
$3.55B |
+$441M |
-$158M |
+$284M |
BLFS, EQRX, FATE, NVTA, ALNY
|
13F-HR |
2/14/2022, 10:19 AM |
| Q3 2021 |
53 |
$4.01B |
+$852M |
-$170M |
+$681M |
NVTAQ, BLFS, EXAS, PACB, FATE
|
13F-HR |
11/15/2021, 03:15 PM |
| Q2 2021 |
54 |
$3.94B |
+$603M |
-$90.3M |
+$513M |
NVTAQ, BLFS, FATE, EXAS, VERV
|
13F-HR |
8/16/2021, 01:56 PM |
| Q1 2021 |
48 |
$3.36B |
+$338M |
-$167M |
+$170M |
NVTAQ, EXAS, FATE, BLFS, PACB
|
13F-HR |
5/17/2021, 02:48 PM |
| Q4 2020 |
52 |
$3.38B |
+$700M |
-$4.24M |
+$696M |
NVTA, BLFS, FATE, EXAS, BPMC
|
13F-HR |
2/16/2021, 12:36 PM |
| Q3 2020 |
45 |
$2.23B |
+$382M |
-$22.1M |
+$360M |
NVTA, BLFS, RLAY, BPMC, FATE
|
13F-HR |
11/16/2020, 01:34 PM |
| Q2 2020 |
42 |
$1.69B |
+$420M |
-$66.6M |
+$354M |
NVTA, BPMC, FATE, SRPT, MYOK
|
13F-HR |
8/14/2020, 04:39 PM |
| Q1 2020 |
38 |
$942M |
+$201M |
-$24.3M |
+$177M |
BPMC, SRPT, ALNY, FATE, CDXS
|
13F-HR |
5/15/2020, 02:02 PM |
| Q4 2019 |
32 |
$1.09B |
+$96.3M |
-$80.8M |
+$15.6M |
SRPT, BLUE, CDXS, BPMC, MYOK
|
13F-HR |
2/14/2020, 03:35 PM |
| Q3 2019 |
33 |
$966M |
+$118M |
-$20.1M |
+$97.8M |
ONCE, NVTA, CDXS, BPMC, SRPT
|
Restatement |
1/3/2020, 08:58 AM |
| Q2 2019 |
31 |
$1.07B |
+$199M |
-$7.76M |
+$191M |
ONCE, NVTA, BPMC, CDXS, SAGE
|
13F-HR |
8/13/2019, 02:11 PM |
| Q1 2019 |
29 |
$910M |
+$122M |
-$17.9M |
+$104M |
ONCE, BPMC, MYOK, SAGE, BLUE
|
13F-HR |
5/15/2019, 03:08 PM |
| Q4 2018 |
31 |
$585M |
+$51.8M |
-$31M |
+$20.8M |
LOXO, MYOK, BPMC, CDXS, ONCE
|
13F-HR |
2/13/2019, 03:42 PM |
| Q3 2018 |
36 |
$823M |
+$190M |
-$4.11M |
+$186M |
LOXO, BPMC, MYOK, AGIO, SAGE
|
13F-HR |
11/14/2018, 09:33 AM |
| Q2 2018 |
35 |
$715M |
+$131M |
-$22.1M |
+$108M |
FMI, LOXO, BPMC, SAGE, MYOK
|
Restatement |
8/20/2018, 04:16 PM |
| Q1 2018 |
31 |
$569M |
+$95.5M |
|
+$95.5M |
LOXO, FMI, SAGE, BPMC, ONCE
|
13F-HR |
5/15/2018, 12:01 PM |
| Q4 2017 |
27 |
$411M |
+$54.5M |
-$469K |
+$54M |
SAGE, FMI, LOXO, BPMC, BLUE
|
13F-HR |
2/14/2018, 07:00 AM |
| Q3 2017 |
26 |
$354M |
+$65.8M |
-$2.49M |
+$63.4M |
LOXO, MYOK, ALNY, SGMO, BPMC
|
13F-HR |
11/14/2017, 07:16 AM |
| Q2 2017 |
35 |
$270M |
+$88.7M |
-$2.69M |
+$86M |
LOXO, SAGE, FMI, BPMC, EVH
|
13F-HR |
8/14/2017, 10:05 AM |
| Q1 2017 |
29 |
$170M |
+$36.1M |
-$23M |
+$13.1M |
SAGE, FMI, LOXO, AGIO, BPMC
|
13F-HR |
5/15/2017, 02:36 PM |
| Q4 2016 |
25 |
$121M |
+$30.9M |
-$5.28M |
+$25.7M |
SAGE, LOXO, AGIO, FMI, EVH
|
13F-HR |
2/14/2017, 12:01 PM |
| Q3 2016 |
26 |
$123M |
+$27.9M |
-$22.4M |
+$5.53M |
AGIO, SAGE, FMI, EVH, BPMC
|
13F-HR |
11/14/2016, 12:20 PM |
| Q2 2016 |
26 |
$99.6M |
+$27.9M |
-$12.1M |
+$15.8M |
ONCE, AGIO, FMI, GBT, LOXO
|
13F-HR |
8/15/2016, 12:45 PM |
| Q1 2016 |
26 |
$87.1M |
+$28.9M |
-$6.71M |
+$22.2M |
LOXO, EPZM, FMI, SAGE, AGIO
|
13F-HR |
5/9/2016, 11:41 AM |
| Q4 2015 |
31 |
$113M |
|
|
|
BPMC, SAGE, LOXO, CTMX, ONCE
|
13F-HR |
2/8/2016, 06:33 AM |